MicroRNA 26a inhibits HMGB1 expression and attenuates cardiac ischemia-reperfusion injury

J Pharmacol Sci. 2016 May;131(1):6-12. doi: 10.1016/j.jphs.2015.07.023. Epub 2015 Aug 4.

Abstract

Ischemia reperfusion (IR) injury is a major issue in cardiac transplantation and inflammatory processes play a major role in myocardial IR injury. MicroRNA 26a (Mir-26a) plays important roles in cellular differentiation, cell growth, cell apoptosis and metastasis. Mir-26a has been demonstrated to modulate regulatory T cells expansion and attenuates renal IR injury. However, the role of Mir-26a in the cardiac IR injury has never been investigated. In our study, hearts of C57BL/6 mice were flushed and stored in cold Bretschneider solution for 8 hours and then transplanted into syngeneic recipients. The results demonstrate a crucial role for Mir-26a in inhibiting high mobility group box-1 (HMGB1) expression and attenuating cardiac IR injury. Mir-26a overexpression results in attenuated cardiac IR injury and inhibited HMGB1 expression. Mir-26a also inhibits inflammatory cells infiltration and cytokines expression. Furthermore, the attenuated cardiac IR injury induced by Mir-26a was abrogated by additional administration of recombinant HMGB1 (rHMGB1). In conclusion, Mir-26a plays a protective role in cardiomyocyte IR injury and this is associated with inhibited HMGB1 expression.

Keywords: Cardiac IR injury; HMGB1; MicroRNA 26a.

MeSH terms

  • Animals
  • Cytokines / genetics
  • HMGB1 Protein / antagonists & inhibitors*
  • HMGB1 Protein / metabolism
  • Heart Transplantation
  • Male
  • Mice, Inbred C57BL
  • MicroRNAs / metabolism*
  • Myocardial Reperfusion Injury / blood
  • Myocardial Reperfusion Injury / drug therapy
  • Myocardial Reperfusion Injury / metabolism*
  • Myocardium / metabolism
  • RNA, Messenger / metabolism
  • Troponin T / blood

Substances

  • Cytokines
  • HMGB1 Protein
  • HMGB1 protein, mouse
  • MicroRNAs
  • Mirn26 microRNA, mouse
  • RNA, Messenger
  • Troponin T